Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
25,57 USD | -0,04% | -1,04% | +12,84% |
14/03 | ANIKA THERAPEUTICS, INC. : Barrington Research ottimista sul caso | ZM |
13/03 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Attività
Numero di dipendenti: 357
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Ostoarthritis Pain Management
61,2
%
| 98 | 62,7 % | 102 | 61,2 % | +4,13% |
Joint Preservation and Restoration
32,9
%
| 50 | 32,3 % | 55 | 32,9 % | +8,88% |
Non-Orthopedic
5,9
%
| 8 | 5,1 % | 10 | 5,9 % | +24,02% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
73,9
%
| 119 | 76,3 % | 123 | 73,9 % | +3,34% |
Other
13,1
%
| 16 | 10,5 % | 22 | 13,1 % | +32,61% |
Europe
13,0
%
| 21 | 13,2 % | 22 | 13,0 % | +5,26% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31/08/18 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 10/08/20 |
Anne Nunes
COO | Chief Operating Officer | 55 | 01/09/21 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 14/10/19 |
Steven Ek
CTO | Chief Tech/Sci/R&D Officer | - | 29/05/20 |
Mark Namaroff
IRC | Investor Relations Contact | 60 | - |
Lisa Funiciello
HRO | Human Resources Officer | - | 01/02/22 |
David Colleran
LAW | General Counsel | 52 | 04/03/20 |
James Chase
SAM | Sales & Marketing | - | 06/08/18 |
Ian McLeod
AUD | Comptroller/Controller/Auditor | - | 01/07/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 23/10/18 |
Sheryl Conley
BRD | Director/Board Member | 63 | 28/10/21 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31/08/18 |
John Henneman
CHM | Chairman | 62 | 03/09/20 |
Glenn Larsen
BRD | Director/Board Member | 70 | 17/02/15 |
Gary Fischetti
BRD | Director/Board Member | 63 | 13/04/23 |
Jeffery Thompson
BRD | Director/Board Member | 58 | 18/01/11 |
Stephen Richard
BRD | Director/Board Member | 61 | 03/09/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 14 848 000 | 14 164 442 ( 95,40 %) | 188 000 ( 1,266 %) | 95,40 % |
Coordinate società
Anika Therapeutics, Inc.
32 Wiggins Avenue
01730, Bedford
+781 457 9000
http://www.anikatherapeutics.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+12,84% | 375 Mln | |
-4,66% | 86,13 Mrd | |
+1,32% | 39,82 Mrd | |
-19,27% | 30,42 Mrd | |
+57,86% | 25,23 Mrd | |
-16,09% | 15,36 Mrd | |
-9,14% | 11,95 Mrd | |
-17,69% | 11,6 Mrd | |
-43,00% | 11,51 Mrd | |
+5,24% | 8,71 Mrd |
- Borsa valori
- Azioni
- Azione ANIK
- Società Anika Therapeutics, Inc.